MARKET WIRE NEWS
  1. Home
  2. Stock
  3. ACAD
  4. News
ACAD
Quote
Short
News
Articles
Message Board

ACADIA Pharmaceuticals Inc. (NASDAQ : ACAD ) News

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) News Releases

ACAD News Releases
ACAD : NASDAQ
Business Wire
Acadia Pharmaceuticals Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
ACAD : NASDAQ
Business Wire
Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
ACAD : NASDAQ
SeekingAlpha
SA Quant ranks UBS' 26 highest conviction names for 2026
ACAD : NASDAQ
SeekingAlpha
Tracking Baker Brothers Portfolio - Q3 2025 Update
ACAD : NASDAQ
KlickAnalytics
Buy Recommendation Issued On ACAD By H.C. Wainwright
ACAD : NASDAQ
Business Wire
Acadia Pharmaceuticals Announces FDA Approval of DAYBUE® STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome
ACAD : NASDAQ
SeekingAlpha
Buy Acadia Pharmaceuticals For Daybue/Nuplazid Stability And Pipeline Optionality
ACAD : NASDAQ
KlickAnalytics
ACAD Price Target Alert: $35.00. Issued by UBS
ACAD : NASDAQ
SeekingAlpha
ACADIA Pharmaceuticals Inc. (ACAD) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
ACAD : NASDAQ
Business Wire
Acadia Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference
Back to Start

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.